Servier

    OverviewSuggest Edit

    Servier is a research-based group dedicated to health care. As the top-ranked French independent pharmaceutical laboratory, Servier reinvests more than 25% of its turnover in Research and Development. As a result, there are currently 29 new drug candidates under development in the following therapeutic areas: cardiology, oncology, metabolism, neuropsychiatry and rheumatology. With a presence on 5 continents and in 146 countries, Servier has put a total of 867 million drug treatments in the hands of patients in 2014. 92% of Servier's medicines are prescribed internationally.
    TypePrivate
    Founded1954
    HQSuresnes, FR
    Websiteservier.com
    Employee Ratings4

    Latest Updates

    Employees (est.) (Oct 2020)10,822
    Job Openings3
    Cybersecurity ratingCMore

    Servier Office Locations

    Servier has offices in Suresnes, Pittsburg, Tulsa, Panama City and in 62 other locations
    Suresnes, FR (HQ)
    50 Rue Carnot
    Sidi M'Hamed, DZ
    Algiers
    Minsk, BY
    303, vulica Miasnikova 70
    Varna, BG
    bul. "Tsar Osvoboditel" 14, ет.4София
    Laval, CA
    235 Boulevard Armand - Frappier
    Toronto, CA
    161 Bay St Suite 2410 (24th floor
    Show all (79)

    Servier Financials and Metrics

    Summary Metrics

    Founding Date

    1954

    Servier Cybersecurity Score

    Cybersecurity ratingPremium dataset

    C

    71/100

    SecurityScorecard logo

    Servier Online and Social Media Presence

    Embed Graph

    Servier News and Updates

    Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors

    DURHAM, N.C. and PARIS, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, in collaboration with Servier, an independent global phar…

    Servier and the Autonomous University of Barcelona collaborate to accelerate research into Parkinsons disease

    Paris (France) and Barcelone (Spain), June, 30 2020 – Servier, an international independent pharmaceutical company, and the Autonomous University of Barcelona (UAB), have signed a partnership agreement to speed up research into Parkinson’s disease, using a new method for small-molecule screening dev…

    Servier Completes the Acquisition of Symphogen

    PARIS, June 4, 2020 /PRNewswire/ -- Servier, an independent international pharmaceutical company, today announced that it has completed the acquisition of Symphogen A/S. Symphogen will now function as Servier's antibody center of excellence across multiple therapeutic areas, including...

    Servier Showcases Robust Presence at ASH 2019

    ORLANDO, Fla., Dec. 4, 2019 /PRNewswire/ -- Servier Group and Servier Pharmaceuticals, the U.S. subsidiary of the global French pharmaceutical company, today announced that data from multiple studies will be presented at the 61st Annual Meeting of the American Society of Hematology (ASH)...

    Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

    Mechelen, Belgium and Paris, France, 11 JUNE 2019, 07.00 CET - Servier and Galapagos NV (Euronext & NASDAQ: GLPG) completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, ahead of schedule.

    Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Data at the 2019 ASCO Annual Meeting

    PRINCETON, N.J., June 3, 2019 /PRNewswire/ -- Taiho Oncology, Inc. and Servier announced today clinical data with LONSURF® (trifluridine and tipiracil, TAS-102) in previously treated patients with metastatic gastric cancer (mGC), metastatic gastroesophageal junction adenocarcinoma (mGEJC) ...
    Show more

    Servier Blogs

    Diabetes: Servier at the virtual EASD congress

    […] L’article Diabetes: Servier at the virtual EASD congress est apparu en premier sur Servier.

    Servier, committed in the fight against childhood cancers

    […] L’article Servier, committed in the fight against childhood cancers est apparu en premier sur Servier.

    Servier Expands CAR-T Oncology Development Collaboration with Precision BioSciences

    […] L’article Servier Expands CAR-T Oncology Development Collaboration with Precision BioSciences est apparu en premier sur Servier.

    Servier participates at the leading European congress on oncology

    […] L’article Servier participates at the leading European congress on oncology est apparu en premier sur Servier.

    Neuropsychiatry: Servier at the ECNP virtual congress

    […] L’article Neuropsychiatry: Servier at the ECNP virtual congress est apparu en premier sur Servier.

    Hypertension: Servier launches a new edition of the public awareness campaign “Because I Say So”

    […] L’article Hypertension: Servier launches a new edition of the public awareness campaign “Because I Say So” est apparu en premier sur Servier.
    Show more

    Servier Frequently Asked Questions

    • When was Servier founded?

      Servier was founded in 1954.

    • How many employees does Servier have?

      Servier has 10,822 employees.

    • Who are Servier competitors?

      Competitors of Servier include Nuformix, Principia BioPharma and Patheon.

    • Where is Servier headquarters?

      Servier headquarters is located at 50 Rue Carnot, Suresnes.

    • Where are Servier offices?

      Servier has offices in Suresnes, Pittsburg, Tulsa, Panama City and in 62 other locations.

    • How many offices does Servier have?

      Servier has 79 offices.